amplified amino tirzepatide Tirzepatide, a dual agonist of glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1), positively impacts the altered microbiota of obese, diabetic, ovariectomized mice Tirzepatide, a dual GIP/GLP-1 receptor

Two main groups of studies are called SURPASS and SURMOUNT

however, larger, longer human trials are needed to confirm their clinical relevance

Published 2015 Apr 28

However, the type of food you eat around your injection time can make a difference in your comfort

Treatment Goals Improve blood sugar control (if diabetic) Promote weight loss (if indicated for obesity) Reduce cardiovascular and metabolic risks Encourage long-term, sustainable lifestyle changes Medication Dosing Schedule Medication: Tirzepatide 10mg/0.5ml + Pyridoxine (B6) 1mg/0.5ml Format: 2ml Vial (Starter Kit lasts 8 weeks) Administration: Subcutaneous injection once weekly How to reconstitute Tirzepatide and Calculate Dosing Use our easy-to-follow Tirzepatide Peptide Calculator to determine your personalized dosing schedule

Certain peptides, such as GLP-1 analogues, are effective for altering body composition and accelerating fat loss